Latest Breaking News On - Democratic progressive party legislator lin - Page 9 : comparemela.com

Phase 2 trial data of a COVID-19 vaccine developed by Medigen Vaccine Biologics Corp (高端疫苗) looked promising, but professional review is needed to assess the vaccine’s efficacy, Minister of Health and Welfare Chen Shih-chung (陳時中) said at a news briefing at the Central Epidemic Command Center yesterday. Medigen announced the results of the vaccine trial on Thursday afternoon, following the Food and Drug Administration’s (FDA) announcement of emergency use authorization standards for locally developed vaccines earlier that day. Despite Medigen’s optimistic outlook, questions have been raised whether the successful phase 2 trial is enough to determine whether the vaccine offers adequate protection

Chen shih chungChuang jen hsiangCentral epidemic command centerUnited biomedical incModerna incDrug administrationMedigen vaccine biologics corpCenters for disease controlDemocratic progressive party legislator linLin chia nanWelfare chen shih chungProgressive party legislator lin chun hsienLegislative yuan parliamentaryDisease controlDirector general chuang jen hsiangLegislative yuan